Brazil’s far-right President Jair Bolsonaro criticized a decision by Argentina’s Senate on Wednesday that gave women the right to decide on abortion. In a post on Twitter, the evangelical head of government said he "deeply ...

Brazil will soon weigh emergency-use approval for AstraZeneca's COVID-19 vaccine after Britain gave the green light on Wednesday, as Latin America's largest country rushes to catch up with immunization programs under way around...

Brazilian syringe and needle makers warned on Wednesday the country's coronavirus vaccination program was at risk after the government set auction prices too low and failed to draw bids for enough syringes to meet its requireme...

Brazil's industry confidence rose 1.8 points in December to 114.9 points, reaching the highest level in more than 10 years, an economic research center said on Monday.

Brazil’s unemployment rate fell unexpectedly to 14.3% in the three months through October, official figures showed on Tuesday, the first decline this year as the number of people with jobs rose by almost 2 million from the pr...

Brazil's Fiocruz biomedical institute will seek approval for the Oxford University/AstraZeneca vaccine against COVID-19 with federal health regulator Anvisa on Jan. 15, one of the center's senior officials said on Monday.

Brazilian President Jair Bolsonaro, one of the world's most prominent coronavirus skeptics, said over the weekend he was not worried about criticism over the speed of Brazil's vaccine rollout, saying he felt no pressure.

Brazil has now moved past the 7 gigawatts (GW) mark of total installed renewables – and has set the ambition of 45% of its energy needs being generated in similar form by 2050.

With the slow development of its own phase three clinical trial of a Covid-19 vaccine candidate, Indonesia said it has asked for data from Brazil, where a similar trial is progressing smoothly.

Brazilian researchers said on Wednesday the COVID-19 vaccine developed by China's Sinovac Biotech is more than 50% effective based on trial data, but again withheld full results at the company's request, raising questions about...